Molecular oncology is at the forefront of cancer research, driving the discovery of new biomarkers and therapeutic targets. The integration of machine learning and artificial intelligence is enhancing our ability to analyze large datasets, leading to novel insights into cancer biology. Collaborative efforts, such as The Cancer Genome Atlas (TCGA), are expanding our understanding of the genomic changes in various cancer types.
